Profound Medical Corp.
PRN.TO
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 179.00K | 773.00K | 428.00K | 0.00 | -- |
| Total Other Revenue | 2.65M | 1.46M | 1.48M | 2.01M | 1.73M |
| Total Revenue | 2.83M | 2.23M | 1.91M | 2.01M | 1.73M |
| Cost of Revenue | 1.03M | 795.00K | 641.00K | 950.00K | 668.00K |
| Gross Profit | 1.81M | 1.44M | 1.27M | 1.06M | 1.06M |
| SG&A Expenses | 6.64M | 5.08M | 4.82M | 5.87M | 4.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.82M | 10.07M | 9.39M | 10.79M | 8.29M |
| Operating Income | -8.99M | -7.83M | -7.48M | -8.78M | -6.56M |
| Income Before Tax | -9.19M | -6.90M | -6.16M | -9.14M | -5.55M |
| Income Tax Expenses | 177.00K | 20.00K | 39.00K | -229.00K | 18.00K |
| Earnings from Continuing Operations | -9.36M | -6.92M | -6.20M | -8.91M | -5.56M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.36M | -6.92M | -6.20M | -8.91M | -5.56M |
| EBIT | -8.99M | -7.83M | -7.48M | -8.78M | -6.56M |
| EBITDA | -8.82M | -7.64M | -7.28M | -8.58M | -6.33M |
| EPS Basic | -0.38 | -0.28 | -0.26 | -0.42 | -0.26 |
| Normalized Basic EPS | -0.23 | -0.18 | -0.16 | -0.27 | -0.16 |
| EPS Diluted | -0.38 | -0.28 | -0.26 | -0.42 | -0.26 |
| Normalized Diluted EPS | -0.23 | -0.18 | -0.16 | -0.27 | -0.16 |
| Average Basic Shares Outstanding | 24.54M | 24.44M | 24.30M | 21.37M | 21.28M |
| Average Diluted Shares Outstanding | 24.54M | 24.44M | 24.30M | 21.37M | 21.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
